79
Views
10
CrossRef citations to date
0
Altmetric
Original

The role of post-remission chemotherapy for older patients with acute myelogenous leukemia

, , , , , & show all
Pages 689-695 | Accepted 18 Feb 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

. (2006) Commentaries. Leukemia & Lymphoma 47:4, pages 569-581.
Read now

Articles from other publishers (9)

Todd L. Rosenblat & Joseph G. Jurcic. (2011) Induction and Postremission Strategies in Acute Myeloid Leukemia: State of the Art and Future Directions. Hematology/Oncology Clinics of North America 25:6, pages 1189-1213.
Crossref
Luis Villela & Javier Bolaños-Meade. (2011) Acute Myeloid Leukaemia. Drugs 71:12, pages 1537-1550.
Crossref
Jacob M. Rowe & Martin S. Tallman. (2010) How I treat acute myeloid leukemia. Blood 116:17, pages 3147-3156.
Crossref
Arati V. Rao & Joseph O. Moore. 2011. Practical Geriatric Oncology. Practical Geriatric Oncology 245 259 .
Jian Min Lin, Betty Li, Eric Rimmer, Melinda VanRoey & Karin Jooss. (2008) Enhancement of the anti-tumor efficacy of a GM-CSF–secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside. Experimental Hematology 36:3, pages 319-328.
Crossref
Jacob M. Rowe. (2008) Consolidation therapy: What should be the standard of care?. Best Practice & Research Clinical Haematology 21:1, pages 53-60.
Crossref
M Kalaycio, L Rybicki, B Pohlman, R Dean, J Sweetenham, S Andresen, R Sobecks, M A Sekeres, A Advani, S Brown & B Bolwell. (2007) Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia. Bone Marrow Transplantation 40:8, pages 753-758.
Crossref
Harry P. Erba. (2007) Prognostic Factors in Elderly Patients with AML and the Implications for Treatment. Hematology 2007:1, pages 420-428.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:4, pages 238-245.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.